AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, paving the way for future treatments.
Gene therapy breakthrough offers hope for severe Dravet syndrome cases
- Post author:admin
- Post published:February 18, 2025
- Post category:uncategorized
- Post comments:0 Comments